These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38875371)

  • 21. Synkinesis in primary and postparalytic hemifacial spasm: Clinical features and therapeutic outcomes of botulinum toxin A treatment.
    Su JH; Yang MN; Teng F; Zhang XL; Pan YG; Hu Y; Xiao LB; Pan LZ; Li LX; Jin LJ
    Toxicon; 2020 Sep; 184():122-126. PubMed ID: 32553733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tear meniscus, corneal topographic and aberrometric changes after botulinum toxin-a injection in patients with blepharospasm and hemifacial spasm.
    Bayraktar Bilen N; Bilen Ş; Topçu Yılmaz P; Evren Kemer Ö
    Int Ophthalmol; 2022 Aug; 42(8):2625-2632. PubMed ID: 35355169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study.
    Defazio G; Abbruzzese G; Girlanda P; Vacca L; Currà A; De Salvia R; Marchese R; Raineri R; Roselli F; Livrea P; Berardelli A
    Arch Neurol; 2002 Mar; 59(3):418-20. PubMed ID: 11890846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of Injection Botulinum Toxin in Blepharospasm.
    Amatya M; Limbu B; Sthapit PR; Gurung HB; Saiju R
    Nepal J Ophthalmol; 2021 Jan; 13(25):40-49. PubMed ID: 33981096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of blepharospasm, hemifacial spasm and facial synkinesis with botulinum toxin].
    Winterhoff J; Laskawi R
    HNO; 2012 Jun; 60(6):479-83. PubMed ID: 22669435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose botulinum toxin a for treatment of blepharospasm and hemifacial spasm.
    Poonyathalang A; Preechawat P; Jamnansiri U
    Jpn J Ophthalmol; 2005; 49(4):327-8. PubMed ID: 16075337
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Riolan's muscle: action and indications for botulinum toxin injection.
    Mackie IA
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():347-52. PubMed ID: 11026998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A patient-initiated treatment model for blepharospasm and hemifacial spasm: a randomized controlled trial.
    Lawes-Wickwar S; McBain H; Brini S; Hirani SP; Hurt CS; Flood C; Dunlop N; Solly D; Crampton B; Newman SP; Ezra DG
    BMC Neurol; 2022 Mar; 22(1):99. PubMed ID: 35300599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blinking Parameters Do Not Normalize After Botulinum Toxin Therapy in Blepharospasm and Hemifacial Spasm Patients.
    Gameiro GR; Osaki MH; Yabumoto C; Osaki T; Garcia DM; Belfort R; Cruz AAV; Osaki TH
    J Neuroophthalmol; 2023 Dec; 43(4):563-568. PubMed ID: 37307066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy.
    Rudzińska M; Wójcik M; Szczudlik A
    J Neural Transm (Vienna); 2010 Jun; 117(6):765-72. PubMed ID: 20467763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [What to do in cases of inadequate effectiveness of botulinum toxin for the treatment of eyelid cramping?].
    Roggenkämper P
    Ophthalmologe; 2007 Sep; 104(9):763-6. PubMed ID: 17726608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm.
    Ho RW; Fang PC; Chao TL; Chien CC; Kuo MT
    Sci Rep; 2018 May; 8(1):8367. PubMed ID: 29849166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pain relief in patients receiving periocular botulinum toxin A.
    Harrison AR; Erickson JP; Anderson JS; Lee MS
    Ophthalmic Plast Reconstr Surg; 2008; 24(2):113-6. PubMed ID: 18356715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the Hemifacial Spasm Grading Scale: a clinical tool for hemifacial spasm.
    Tambasco N; Simoni S; Sacchini E; Eusebi P; Marsili E; Nigro P; Brahimi E; Paoletti FP; Romoli M; Calabresi P
    Neurol Sci; 2019 Sep; 40(9):1887-1892. PubMed ID: 31076941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
    J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin A is effective to treat tension-type headache caused by hemifacial spasm.
    Mizuma A; Nagata E; Yasuda T; Kouchi M; Nakayama T; Honma K; Tokuoka K; Kitagawa Y; Nogawa S; Takizawa S
    J Clin Neurosci; 2017 Oct; 44():284-288. PubMed ID: 28734794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing the area and varying the dosage of Botulinum toxin a injections for effective treatment of hemifacial spasm.
    Choe WJ; Kim J
    Acta Otolaryngol; 2016 Sep; 136(9):952-5. PubMed ID: 27067535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of botulinum A toxin repeated injection in treating blepharospasm and hemifacial spasm].
    Wang J; Zhang X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Apr; 20(7):292-4. PubMed ID: 16780139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia].
    Oliveira FC; Oliveira GC; Cariello AJ; Felberg S; Osaki MH
    Arq Bras Oftalmol; 2010; 73(5):405-8. PubMed ID: 21225122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.